← Leaderboards
Wanli W Smith
Johns Hopkins University
$8,415,706
Attributed
$12,180,625
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2M · FY2006–25$2.5M$1.9M$1.3M$625K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,180,625 · 7
By mechanism
R01$11,327,151 · 5
R21$853,474 · 2
Top collaborators
- Jun Hua7 shared
- Christopher A Ross5 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Valina L. Dawson$28,150,357
- Ted M. Dawson$31,695,689
- Christopher A Ross$35,771,871
- Jun Hua$8,371,908
- Andrew Hoover Karaba$1,768,787
Others in their field
Top investigators on “Parkinson Disease”
- Tatiana M. Foroud · Indiana Univ-Purdue Univ At Indianapolis$92,426,001
- David M Anderson · University Of Washington$40,483,703
- Daniel M Corcos · Northwestern University$37,632,589
- Joel Synes Perlmutter · Washington University$37,192,743
- Jerrold L Vitek · University Of Minnesota$35,135,315
- Joseph B Martin · Harvard University (Medical School)$26,652,023
Research focus
Parkinson DiseasePathogenesisNeuronsGeneticLrrk2 GeneMutationMutantCellsNeurodegenerative DisordersPhosphotransferasesMolecularGtp BindingInsightProteinsBiologicalPathogenicityIn VitroSignal TransductionPlayOverexpressionBrainBrain TissueDopaminergic NeuronDisease Progression
Grant awards (26)
Dysfunction of brain microvascular and lymphatic vessels in obesity-linked cognitive impairment$801,348
R01 · FY2025 · AG · contact PI
LRRK2 and inflammasome pathway in Parkinson's disease$609,816
R01 · FY2025 · NS · contact PI
Advanced MRI studies of cerebrovascular and lymphatic abnormalities in LRRK2 mouse models of Parkinson's disease$603,130
R01 · FY2025 · NS · contact PI
LRRK2 and inflammasome pathway in Parkinson's disease$607,790
R01 · FY2024 · NS · contact PI
Advanced MRI studies of cerebrovascular and lymphatic abnormalities in LRRK2 mouse models of Parkinson's disease$602,962
R01 · FY2024 · NS · contact PI
LRRK2 and inflammasome pathway in Parkinson's disease$642,851
R01 · FY2023 · NS · contact PI
Advanced MRI studies of cerebrovascular and lymphatic abnormalities in LRRK2 mouse models of Parkinson's disease$629,149
R01 · FY2023 · NS · contact PI
Advanced MRI Studies of Cerebrovascular and Lymphatic Abnormalities in LRRK2 mouse models of Parkinson's disease$407,342
R01 · FY2023 · NS · contact PI
LRRK2 and inflammasome pathway in Parkinson's disease$658,627
R01 · FY2022 · NS · contact PI
Advanced MRI studies of cerebrovascular and lymphatic abnormalities in LRRK2 mouse models of Parkinson's disease$635,611
R01 · FY2022 · NS · contact PI
LRRK2 and inflammasome pathway in Parkinson's disease$673,122
R01 · FY2021 · NS · contact PI
Advanced MRI studies of cerebrovascular and lymphatic abnormalities in LRRK2 mouse models of Parkinson's disease$658,091
R01 · FY2021 · NS · contact PI
LRRK2, KIF5A and Parkinson disease$416,337
R01 · FY2020 · NS · contact PI
LRRK2, KIF5A and Parkinson disease$416,832
R01 · FY2019 · NS · contact PI
LRRK2, KIF5A and Parkinson disease$417,310
R01 · FY2018 · NS · contact PI
LRRK2, KIF5A and Parkinson disease$417,316
R01 · FY2017 · NS · contact PI
LRRK2 dimerization and therapeutic evaluation$240,186
R21 · FY2017 · NS · contact PI
LRRK2, KIF5A and Parkinson disease$469,163
R01 · FY2016 · NS · contact PI
LRRK2 dimerization and therapeutic evaluation$214,528
R21 · FY2016 · NS · contact PI
Synphilin-1 and Obesity$316,766
R01 · FY2014 · DK · contact PI
Synphilin-1 and Obesity$305,680
R01 · FY2013 · DK · contact PI
Synphilin-1 and obesity$316,766
R01 · FY2012 · DK · contact PI
Synphilin-1 and obesity$319,642
R01 · FY2011 · DK · contact PI
Synphilin-1 and obesity$401,500
R01 · FY2010 · DK · contact PI
LRRK2 and cellular pathways of Parkinson's Disease$214,870
R21 · FY2007 · NS · contact PI
LRRK2 and cellular pathways of Parkinson's Disease$183,890
R21 · FY2006 · NS · contact PI